pyrrolidonecarboxylic acid has been researched along with Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, W; Wang, P; Wang, Y; Xu, X; Zhang, Y; Zhao, C; Zhao, Z | 1 |
| Bakker, NAM; Brandsma, AM; Brummelkamp, TR; Fauster, A; Franke, K; Gomez-Eerland, R; Haanen, JBAG; Jansen, JHM; Leusen, JHW; Logtenberg, MEW; Marijt, KA; Matlung, HL; Neefjes, J; Raaben, M; Scheeren, FA; Schumacher, TN; Toebes, M; van den Berg, JH; van den Berg, TK; van der Schot, S; Verdoes, M | 1 |
| BARENDREGT, TJ; KLEIN, AJ; KOGL, F | 1 |
| Baranyai, Z; Kapuvári, B; Leurs, U; Manea, M; Marquardt, A; Mezo, G; Öhlschläger, P; Orbán, E; Schulcz, Á; Tejeda, M; Tóvári, J | 1 |
| Marshall, E | 1 |
| Benetti, GP; Bombelli, G; Fugazza, L; Illeni, MT; La Vecchia, G; Montalto, F; Stramba Badiale, M; Uslenghi, C | 1 |
| Aakvaag, A; Frostad, S; Kalland, T; Laerum, OD | 1 |
| Auteri, A; Bova, G; Bruni, F; Chiarion, C; Di Renzo, M; Ferrì, P; Girardello, R; Pasqui, AL; Saletti, M | 1 |
| Ali-Osman, F; Srivenugopal, KS | 1 |
| Alpert, LC; Batist, G; Chen, X; Griffith, OW; Hayward, MA; Schecter, RL | 1 |
| Batist, G; Carystinos, GD; Chen, X | 1 |
| Alonso-Varona, A; Bilbao, J; Bilbao, P; Castro, B; del Olmo, M; Palomares, T | 1 |
| DeGraff, W; Friedman, N; Mitchell, JB; Russo, A | 1 |
3 review(s) available for pyrrolidonecarboxylic acid and Neoplasms
| Article | Year |
|---|---|
Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases.
Topics: Alzheimer Disease; Aminoacyltransferases; Amyloid beta-Peptides; CD47 Antigen; Humans; Neoplasms; Neurodegenerative Diseases; Pyrrolidonecarboxylic Acid | 2022 |
Haemopoietic stem cell inhibition: potential for dose intensification.
Topics: Antineoplastic Agents; Cell Cycle; Chemokine CCL4; Cytokines; Dose-Response Relationship, Drug; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Macrophage Inflammatory Proteins; Monokines; Neoplasms; Oligopeptides; Pyrrolidonecarboxylic Acid | 1995 |
Potential for selective modulation of glutathione in cancer chemotherapy.
Topics: Animals; Buthionine Sulfoximine; Cell Communication; Drug Resistance; Enzyme Inhibitors; Female; Gap Junctions; Glutamate-Cysteine Ligase; Glutathione; Humans; Mammary Neoplasms, Experimental; Neoplasms; Prodrugs; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid; Rats; Thiazoles; Thiazolidines | 1998 |
1 trial(s) available for pyrrolidonecarboxylic acid and Neoplasms
| Article | Year |
|---|---|
Ex vivo evaluation of pidotimod activity on cell-mediated immunity.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; CD3 Complex; Double-Blind Method; Female; Humans; Immunity, Cellular; Lymphocyte Count; Male; Middle Aged; Neoplasms; Phytohemagglutinins; Pyrrolidonecarboxylic Acid; Stimulation, Chemical; T-Lymphocytes; Thiazoles; Thiazolidines | 1994 |
9 other study(ies) available for pyrrolidonecarboxylic acid and Neoplasms
| Article | Year |
|---|---|
Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy.
Topics: Aminoacyltransferases; Animals; Antigens, Differentiation; CD47 Antigen; Cell Line, Tumor; Cell Membrane; Humans; Immunotherapy; Mice, Transgenic; Neoplasms; Opsonin Proteins; Pyrrolidonecarboxylic Acid; Receptors, Immunologic | 2019 |
Excretion of D-pyrrolidone carboxylic acid by rat and dog fed with tumour proteins.
Topics: Animals; Biological Transport; Body Fluids; Carboxylic Acids; Dogs; Neoplasm Proteins; Neoplasms; Proteins; Pyrrolidonecarboxylic Acid; Rats | 1948 |
Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4.
Topics: Amino Acid Sequence; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Daunorubicin; Drug Stability; Female; Gonadotropin-Releasing Hormone; Humans; Lysosomes; Mice; Mice, Inbred BALB C; Neoplasms; Protein Structure, Secondary; Pyrrolidonecarboxylic Acid; Rats; Serum | 2011 |
Hemoregulatory peptide (HP5b) dimer effects on normal and malignant cells in culture.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Bone Marrow; Bone Marrow Cells; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cells, Cultured; Colony-Forming Units Assay; Female; Glioblastoma; Glioma; Hematopoietic Stem Cells; Interleukin-3; Lymphocyte Activation; Lymphocyte Subsets; Lymphoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Molecular Sequence Data; Neoplasms; Oligopeptides; Polymers; Pyrrolidonecarboxylic Acid; Tumor Cells, Cultured | 1993 |
The in vitro effect of Pidotimod on some immune functions in cancer patients.
Topics: Adjuvants, Immunologic; Female; Humans; Immunity, Cellular; Immunologic Factors; Interleukin-2; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Neoplasms; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1997 |
Activity and distribution of the cysteine prodrug activating enzyme, 5-oxo-L-prolinase, in human normal and tumor tissues.
Topics: Cysteine; Humans; Neoplasms; Prodrugs; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1997 |
Characterization of 5-oxo-L-prolinase in normal and tumor tissues of humans and rats: a potential new target for biochemical modulation of glutathione.
Topics: Animals; Female; Glutathione; Humans; Immunohistochemistry; Neoplasms; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred F344; Thiazoles; Thiazolidines | 1998 |
L-2-Oxothiazolidine-4-carboxylate reverses the tumour growth-promoting effect of interleukin-2 and improves the anti-tumour efficacy of biochemotherapy in mice bearing B16 melanoma liver metastases.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Female; Glutathione; Interleukin-2; Liver; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Time Factors; Tumor Cells, Cultured | 2002 |
Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs.
Topics: Antineoplastic Agents; Bleomycin; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Cisplatin; Glutathione; Humans; Lung; Lung Neoplasms; Melphalan; Methionine Sulfoximine; Neoplasms; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Zinostatin | 1986 |